Abstract
The MS-Lab project wants to implement a non-pharmacological method of multisensory stimulation aimed at reducing the sense of discomfort and improving the psycho-behavioral disorders typical of subjects with severe dementia, with the aim of improving the quality of life of patients, verifying effectiveness and safety of this method. This technological implementation is made possible by a wide and complex collaboration between organizations and companies with different skills. As described by practice and theory, appropriate sensory stimulation can lead to several improvements, such as: greater initiative of patients, greater vigilance, improvement in mood and interpersonal relations, greater attention and confusional state reduction. Moreover, positive effects could derive from the possible reduction of drugs and/or psychotropic drugs, with consequent reduction of pharmacological side effects and reduction of health costs, as well as decrease in the need for physical restraint. MS-Lab is experimenting a non-pharmacological therapy through a multisensory stimulation and intend to overcome some limits detected in this type of treatment, improving its effectiveness by supporting a framework designed as a complex system of input and output devices driven by an intelligent system able to modulate sensory stimuli according to the continuously measured biological parameters. The project also proposes to define a detailed protocol with an algorithm at the base of a dedicated software, in order to make this experience repeatable, producing data that can be freely used by experts, re-proposing it in a clinical contest or in any other environments to be defined ad hoc. Moreover, a multiplatform software layer will be designed and implemented to support Clinical Decisions (CDSS), supporting caregivers through suitable graphic interfaces on mobile devices, suggesting the most appropriate domains to be stimulated on the basis of current and past clinical parameters acquired from sensors’ ecosystem. MS-Lab will be installed at “Casa Amata”—a nursing home located in Taviano (Le), Italy—and at “Casa Sollievo della Sofferenza” —an hospital and Research Institution located in S. Giovanni Rotondo (Fg), Italy—with the aim of conducting simultaneous and co-planned experiments through the proposed treatment able to represent the best answer to the end-user needs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM et al (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21:383–421
Almirall E, Casadesus-Masanell R (2010) Open versus closed innovation: a model of discovery and divergence. Acad Manag Rev 35(1):27–47
Appelhans BM, Luecken LJ (2006) Heart rate variability as an index of regulated emotional responding. Rev Gen Psychol 10(3):229–240
Ardito L, Messeni Petruzzelli A (2017) Breadth of external knowledge sourcing and product innovation: the moderating role of strategic human resource practices. Eur Manag J 35(2):261–272
American Psychiatric Association (1952) Manuale diagnostico e statistico dei disturbi mentali quinta edizione DSM V. Raffaello Cortina Editore, pp 687–746
Beauchaine T (2001) Vagal tone, development, and Gray’s motivational theory: toward an integrated model of autonomic nervous system functioning in psychopathology. Dev Psychopathol 13(2):183–214
Berntson GG, Cacioppo JT, Quigley KS (1991) Autonomic determinism: the modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint. Psychol Rev 98(4):459
Berntson GG, Cacioppo JT, Quigley KS (1993) Respiratory sinus arrhythmia: autonomic origins, physiological mechanisms, and psychophysiological implications. Psychophysiology 30(2):183–196
Bessant J, Künne C, Möslein K (2012) Opening up healthcare innovation: innovation solutions for a 21st century healthcare system. AIM Research, United Kingdom
Bianchi M, Cavaliere A, Chiaroni D, Frattini F, Chiesa V (2011) Organisational modes for open innovation in the bio-pharmaceutical industry: an exploratory analysis. Technovation 31(1):22–33
Cacioppo JT, Tassinary LG, Berntson GG (2007) Handbook of psychophysiology. Cambridge University Press, New York, NY
Casacci P, Pistoia M, Leone A, Caroppo A, Siciliano P (2015) Alzheimer patient’s home rehabilitation through ICT advanced technologies: the ALTRUISM project. In: Andò B, Siciliano P, Marletta V, Monteriù A (eds) Ambient assisted living. Bio-systems and biorobotics, vol 11. Springer, Cham
Chang S, Li SJ, Chiang MJ, Hu SJ, Hsyu MC (2007) Fractal dimension estimation via spectral distribution function and its application to physiological signals. IEEE Trans Biomed Eng 54(10):1895–1898
Chung JC, Lai CK (2002) Snoezelen for dementia. Cochrane Database System Rev (4)
Chesbrough H (2003) The logic of open innovation: managing intellectual property. California Manag Rev 45(3):33–58
Chesbrough H, Bogers M (2014) Explicating open innovation: clarifying an emerging paradigm for understanding innovation. In: Chesbrough H, Vanhaverbeke W, West J (eds) New frontiers in open innovation. Oxford University Press, Oxford, pp 3–28
Chesbrough H, Crowther AK (2006) Beyond high tech: early adopters of open innovation in other industries. R&D Manag 36(3):229–236
Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ et al (2012) Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflamm 9:1–18
Dahlander L, Gann DM (2010) How open is innovation? Res Policy 39(6):699–709
Davis MM, Freeman M, Kaye J, Vuckovic N, Buckley DI (2014) A systematic review of clinician and staff views on the acceptability of incorporating remote monitoring tech-nology into primary care. Telemed E-Health 20:428–438
Dawson ME, Schell AM, Filion DL (2007) The electrodermal system. In: Handbook of psychophysiology, vol 2, pp 200–223
Enkel E (2010) Attributes required for profiting from open innovation in networks. Int J Technol Manag 52(3/4):344–371
Farooq K, Khan BS, Niazi MA, Leslie SJ, Hussain A (2017) Clinical decision support systems: a visual survey
Faust O, Hagiwara Y, Hong TJ, Lih OS, Acharya UR (2018) Deep learning for healthcare applications based on physiological signals: a review. Comput Methods Programs Biomed 161:1–13
Goldstein S, Naglieri JA, Princiotta D, Otero TM (2014) Introduction: a history of executive functioning as a theoretical and clinical construct. In: Handbook of executive functioning. Springer, New York, NY, pp 3–12
Grossman P, Taylor EW (2007) Toward understanding respiratory sinus arrhythmia: relations to cardiac vagal tone, evolution and biobehavioral functions. Biol Psychol 74(2):263–285
Huizingh EK (2011) Open innovation: state of the art and future perspectives. Technovation 31(1):2–9
Szeto JYY, Lewis SJG (2016) Current treatment options for Alzheimer’s disease and Parkinson’s disease dementia. Curr Neuropharmacol 14:326–338
Kim JW, Stewart R, Kang HJ, Bae KY, Kim SW, Shin IS, Yoon JS, Kim JM (2018) Longitudinal associations between serum cytokine levels and dementia. Front Psychiatry. Nov 19; 9:606
Leydesdorff L (2012) The triple helix, quadruple helix, …, and an N-tuple of helices: explanatory models for analyzing the knowledge-based economy? J Knowl Econ 3(1):25–35
Lichtenthaler E (2004) Organising the external technology exploitation process: current practices and future challenges. Int J Technol Manag 27(2–3):255–271
McEwen BS (2008) Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583(2–3):174–185
Mulgan G, Tucker S, Ali R, Sanders B (2007) Social innovation: what it is, why it matters and how it can be accelerated. https://eureka.sbs.ox.ac.uk/761/1/Social_Innovation.pdf. Accessed on 23 March 2017
Musen MA, van Bemmel JH (1997) Handbook of medical informatics. Bohn Stafleu Van Loghum, Houten, the Netherlands
OECD (2018) Care needed: improving the lives of people with dementia. In: OECD health policy studies. OECD Publishing, Paris
Perry VH, Cunningham C, Holmes C (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immun 7:161–167
Plsek PE, Wilson T (2001) Complexity, leadership, and management in healthcare organisations. BMJ 323(7315):746–749
Raimondi G, Casacci P, Sancesario G, Scordamaglia B, Melchiorri G, Pistoia M (2017) Telemedicine for dementia-affected patients: the AAL-ACCESS project experience. In: Cavallo F, Marletta V, Monteriù A, Siciliano P (eds) Ambient assisted living. ForItAAL 2016. Lecture notes in electrical engineering, vol 426. Springer, Cham
Satti R, Noor-Ul-Hoda Abid MB, De Rui M, Garrido M, Rauofy MR, Montagnese S, Mani AR (2019) The application of the extended Poincaré plot in the analysis of physiological variabilities. In: Frontiers in physiology, vol 10
Secundo G, Toma A, Schiuma G, Passiante G (2019) Knowledge transfer in open innovation: A classification framework for healthcare ecosystems. Bus Process Manag J 25(1):144–163
Society for Psychophysiological Research Ad Hoc Committee on Electrodermal Measures, Boucsein W, Fowles DC, Grimnes S, Ben‐Shakhar G, Roth WT, Filion DL et al (2012) Publication recommendations for electrodermal measurements. Psychophysiology 49(8):1017–1034
Takeda M, Tanaka T, Okochi M, Kazui H (2012) Non-pharmacological intervention for dementia patients. Psychiatry Clin Neurosci 66(1):1–7
Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S et al (1997) Intrathecal release of proand anti-inflammatory cytokines during stroke. Clin Exp Immunol 110:492–499
Verheul A (2005) Fundamental philosophy of Snoezelen–historical backround, planning and concept. In: Mertens K, Verheul A (eds) Teoksessa Snoezelen–application fields in practise. ISNA, Germany and the Netherlands, pp 25–54
Von Hippel E (1986) Lead users: a source of novel product concepts. Manage Sci 32(7):791–805
Walshok ML, Shapiro JD, Owens N (2014) Transnational innovation networks aren’t all created equal: towards a classification system. J Technol Trans 39(3):345–357
Williamson PJ, De Meyer A (2012) Ecosystem advantage. California Manag Rev 55(1):24–46
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Boccadamo, A. et al. (2021). Multi Sensorial Stimulation Lab: A New Approach for Severe Dementia. In: Monteriù, A., Freddi, A., Longhi, S. (eds) Ambient Assisted Living. ForItAAL 2019. Lecture Notes in Electrical Engineering, vol 725. Springer, Cham. https://doi.org/10.1007/978-3-030-63107-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-63107-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-63106-2
Online ISBN: 978-3-030-63107-9
eBook Packages: EngineeringEngineering (R0)